跳至主要内容
临床试验/NCT01694225
NCT01694225已完成不适用

Estimating the Adherence Rate of a Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors

University of Louisville2 个研究点 分布在 1 个国家目标入组 87 人开始时间: 2012年7月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
87
试验地点
2

研究概览

简要总结

This study aims to establish the feasibility of using a monthly bubble package to improve compliance rates among women prescribed adjuvant endocrine therapy.

详细描述

This study uses Bubble packaging to provide a cost effective way to improve compliance and help direct further interventions to ensure adherence in women on anti-estrogen therapy for breast cancer.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 18 years of age or older
  • Estrogen receptor positive (> 1% estrogen expression) by immunohistochemistry
  • Invasive breast cancer (stage I, II, III) or DCIS considered for adjuvant endocrine therapy

排除标准

  • Patients with metastatic disease (stage IV)
  • Patients less than 18 years of age
  • Prisoners
  • Patients are unable to fill prescriptions at the BCC pharmacy due to insurance limitations or personal preference

研究组 & 干预措施

bubble package for monthly prescription

Experimental

use of bubble packaging for monthly prescription

干预措施: bubble packaging for monthly prescription (Other)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Elizabeth Riley

Associate Professor

University of Louisville

研究点 (2)

Loading locations...

相似试验